glp-1 supergut Unflavored Booster 15 digestion and heart health* Supergut GLP-1 Daily Support Prebiotic

The challenge is that these symptoms are non-specific and overlap with many other conditions, including Lyme disease, fibromyalgia, chronic fatigue syndrome, and autoimmune disorders

Oral antibiotics, including low-dose doxycycline, address stubborn cases that do not respond to topical treatment alone

Ready to discover how fast you can lose weight with medically supervised GLP-1 therapy

Phase 2 trial data for the CagriSema combination (cagrilintide 2.4mg + semaglutide 2.4mg) demonstrated approximately 15.6% mean weight reduction at 32 weeks substantially exceeding semaglutide alone and positioning amylin/GLP-1 dual agonism as a competitive research frontier alongside GIP/GLP-1 and triple agonist approaches

Rapamycin significantly inhibits the activity of arthritis and improves immune function in RA mice [117, 118]